Edition:
United States

Evolus Inc (EOLS.O)

EOLS.O on Consolidated Issue listed on NASDAQ Global Market

28.30USD
19 Jun 2018
Change (% chg)

$0.04 (+0.14%)
Prev Close
$28.26
Open
$27.97
Day's High
$30.19
Day's Low
$27.95
Volume
96,480
Avg. Vol
--
52-wk High
$39.50
52-wk Low
$6.75

Chart for

About

Evolus, Inc. is a medical aesthetics company. The Company is focused on providing physicians and aesthetic procedures and treatments. It also focuses on offering the self-pay aesthetic market and its product candidate, PrabotulinumtoxinA (DWP-450), is an injectable 900 kilodalton, or kDa, botulinum toxin type designed to address... (more)

Overall

Beta: --
Market Cap(Mil.): $669.50
Shares Outstanding(Mil.): 23.64
Dividend: --
Yield (%): --

Financials

  EOLS.O Industry Sector
P/E (TTM): -- 241.68 34.14
EPS (TTM): -0.15 -- --
ROI: -- -5.91 13.17
ROE: -- -7.75 15.14

BRIEF-Evolus Announces Pricing Of Initial Public Offering Of Common Stock

* EVOLUS, INC. ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING OF COMMON STOCK

Feb 07 2018

BRIEF-Evolus Inc Sees IPO Priced To Be Between $12 And $14 Per Share

* EVOLUS INC SEES IPO OF 5 MILLION SHARES PRICED TO BE BETWEEN $12 AND $14 PER SHARE – SEC FILING‍​

Jan 29 2018

Earnings vs. Estimates